Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fondaparinux

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 702,331Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Blank

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Fondaparinux Sodium
    arrow
    2024 ACI Convention
    Not Confirmed

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2007-01-30

    Date Granted :

    Fondaparinux Sodium

    Brand Name :

    Patent Number : 1265132

    Filing Date :

    Strength per Unit :

    Dosage Form :

    Human Or VET :

    Route of Administration :

    Patent Expiration Date : 2007-01-30

    Date Granted :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Fondaparinux Sodium
    arrow
    2024 ACI Convention
    Not Confirmed

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2007-01-30

    Date Granted :

    Fondaparinux Sodium

    Brand Name :

    Patent Number : 1265132

    Filing Date :

    Strength per Unit :

    Dosage Form :

    Human Or VET :

    Route of Administration :

    Patent Expiration Date : 2007-01-30

    Date Granted :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF